ENDRA Life Sciences Inc. (NDRA) · Peers
ENDRA Life Sciences against the 31 other companies here in its SEC industry, Electromedical & Electrotherapeutic Apparatus. Each figure is the one on the company's own page; the median is the peers', and the rank is among all 32, highest first.
Measure by measure
| Measure | NDRA | Peer median | Rank |
|---|---|---|---|
| Market value | $7.11M | median $75.33M | 27 of 32 |
| P/S | 115.2× | median 3.0× | 3 of 31 |
| FCF yield | -68.1% | median -5.8% | 30 of 32 |
| ROIC | -115.0% | median -19.0% | 15 of 21 |
| ROE | -93.8% | median -24.5% | 18 of 26 |
| Revenue growth (4y, yearly) | -35.2% | median 4.2% | 24 of 26 |
| Current ratio | 7.1× | median 3.0× | 7 of 32 |
| Share count change | 289.8% | median 13.2% | 4 of 31 |
Green where ENDRA Life Sciences is on the better side of the median, red where on the worse; no colour where higher is neither, like size or dividend yield.
The peers, largest first
| Company | Market value | P/E | ROIC | Score |
|---|---|---|---|---|
| NDRAENDRA Life Sciences Inc. | $7.11M | P/E – | -115.0% | 3.1 |
| MDTMedtronic plc | $121.28B | P/E 25.3× | 7.5% | 5.4 |
| ITGRInteger Holdings Corp | $4.31B | P/E 33.5× | 4.7% | 4.6 |
| LIVNLivaNova PLC | $4.27B | P/E 22.7× | 13.4% | 5.6 |
| TMDXTransMedics Group, Inc. | $2.45B | P/E 16.2× | 7.9% | 5.4 |
| BLFSBiolife Solutions Inc | $1.89B | P/E – | 0.4% | 4.1 |
| AXGNAxogen, Inc. | $1.86B | P/E – | -5.3% | 4.7 |
| CNMDCONMED Corp | $1.40B | P/E 29.7× | 4.4% | 5.0 |
| CBLLCeribell, Inc. | $960.99M | P/E – | – | 4.4 |
| INMDInMode Ltd. | $897.16M | P/E 9.6× | 22.7% | 6.3 |
| CVCapsoVision, Inc | $326.81M | P/E – | -180.9% | 2.8 |
| ELMDElectromed, Inc. | $227.04M | P/E 22.5× | 32.1% | 6.8 |
| FOCLEdap TMS SA | $153.49M | P/E – | -135.1% | 3.5 |
| STXSStereotaxis, Inc. | $101.20M | P/E – | -1026.1% | 3.6 |
| VANIVivani Medical, Inc. | $101.03M | P/E – | – | 3.2 |
| NRXSNeuraxis, INC | $96.69M | P/E – | – | 4.0 |
| HYPRHyperfine, Inc. | $75.33M | P/E – | -406.4% | 5.2 |
| OMOutset Medical, Inc. | $74.06M | P/E – | -110.8% | 4.4 |
| ECORelectroCore, Inc. | $70.77M | P/E – | – | 4.9 |
| ITOCiTonic Holdings Ltd | $61.58M | P/E – | -128.2% | 2.7 |
| NXLNexalin Technology, Inc. | $51.79M | P/E – | – | 3.2 |
| VASOVASO Corp | $51.05M | P/E 20.4× | – | 5.8 |
| POSCPositron Corp | $50.91M | P/E – | – | 1.8 |
| POCIPrecision Optics Corporation, Inc. | $47.28M | P/E – | -32.7% | 4.7 |
| QTIQT Imaging Holdings, Inc. | $35.13M | P/E – | -190.8% | 4.7 |
| GTHPGuided Therapeutics Inc | $18.34M | P/E – | – | 3.4 |
| IRIXIridex Corp | $14.31M | P/E – | – | 4.5 |
| ADMTADM Tronics Unlimited, Inc. | $3.38M | P/E – | -60.0% | 3.7 |
| HCILHongchang International Co., Ltd | $3.01M | P/E 1.2× | 4.4% | 6.4 |
| NUWENuwellis, Inc. | $2.00M | P/E – | – | 3.8 |
| ESMCEscalon Medical Corp | $1.26M | P/E – | -88.0% | 4.7 |
| YBGJYubo International Biotech Ltd | $886,165 | P/E – | – | 3.5 |
The industry is the Standard Industrial Classification code the company registered with the SEC. It is a broad label: a peer group is a starting point for comparing, not proof that two businesses are alike. None of this is advice.